NOWDiagnostics: OTC And POC Diagnostic Test Company Raises $22.5 Million In Series B
By Amit Chowdhry ● Jul 15, 2024
NOWDiagnostics (NOWDx), a developer of over the counter (OTC) and point-of-care (POC) diagnostic tests, announced it has raised $22.5 million in Series B financing. Led by DigitalDx Ventures, with notable investment from the Labcorp Venture Fund and Kompass Kapital Management, this oversubscribed funding round will be used to drive the commercialization of at-home diagnostic tests, continue developing new diagnostic innovations, expand the pipeline of tests, and support strategic hiring initiatives.